Clinical trial · Observational
Symptom Clusters in Cancer Patients and Their Caregivers- a Longitudinal Study
Advancing the Science of Symptom Management and Support for Cancer Patients and Their Caregivers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The complexity of cancer patients' symptoms and health problems constitutes considerable distress and burden for patients and their family caregivers. To help them manage the illness effectively, there is a need to better understand the complexity of symptoms and symptom clusters in patients and caregivers. Therefore, the purpose of this research is to explore a set of important fundamental research questions to advance the scientific knowledge of cancer patients' and caregivers' symptoms, symptom clusters and health-related quality of life. The investigators will follow 500 cancer patients and their caregivers with repeated measures over 6 months to assess their symptoms, symptom clusters, and quality of life over time. Caregiver burden will also be examined in the caregivers.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Depression | — | UNRESOLVED | — |
| Fatigue | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
| Sleeping Problems | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- Not hospitalized cancer patients under active treatment
- label
- 2
- description
- Caregivers of these cancer patients
Primary outcomes (1)
- measure
- Physical functioning and quality of life
- timeFrame
- 5 to 8 times during 6 months
Secondary outcomes (1)
- measure
- Symptoms will be measured both in patients and caregivers. Caregiver burden will be measured in the caregivers. A blood sample for genetic testing will be taken from the patients once
- timeFrame
- 5 to 8 times during 6 months for patients. Three times during 6 months for caregivers.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria for patients are: * diagnosed with breast, colon, head and neck or ovarian cancer * receiving active treatment for their cancer (chemo- or radiation therapy) * above 18 years of age * able to read / write /speak Norwegian. Inclusion criteria for caregivers: * above 18 years * read and speak Norwegian * and written informed consent. Exclusion Criteria: * patients who had received radiation on the brain as this may affect their abilities to reliably complete questionnaires.
References
Publications (0)
Data not yet available